Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

CGF and i-PRF are more effective and safer than PRP for treating female pattern hair loss.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

A new mutation in the HJV gene was found in a young woman with juvenile hemochromatosis, causing unusual symptoms like secondary hypothyroidism.

The test and reference finasteride tablets are bioequivalent.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

PP405 may help hair growth by activating hair follicle stem cells.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Medroxyprogesterone acetate iontophoresis safely and effectively reduces facial hair growth in women.

AP collagen peptides help hair grow and improve hair health.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Early hair loss may indicate prostate issues.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The UHS promoter is specific to mouse hair follicles.

Seven genes are highly expressed in both germ-line and hematopoietic stem cells.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

A boy and his father with hereditary hypotrichosis simplex were treated for hair loss, but the treatment result is unknown.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Ginsenosides Rb₁ and Rd may help prevent hair loss by promoting hair cell growth.

The document's conclusion cannot be provided because the document is not readable.

The IBHRS is now operational.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.